[ad_1]
TORONTO, July 18, 2022 /CNW/ – Nurosene Health Inc. (“Nurosene” or the “Company”) (CSE:MEND) (Frankfurt: 8TV) (OTC:MNNDF), a healthtech company focused on delivering innovative AI-based technology solutions for mental performance and wellness, appoints seasoned financial executive Swapan Kakumanu as Chief Financial Officer.
“We are excited to welcome Swapan to our senior executive team. This appointment continues to demonstrate our commitment to building a world class management team. Swapan is a proven CFO with a great track record of delivering results in the capital market space. He will be a great addition to the Nurosene team and we look forward to the value that…
Full story available on Benzinga.com
[ad_2]
Source link
